These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Case-control study of BCG vaccination as a risk factor for leprosy and tuberculosis in western Kenya. Orege PA, Fine PE, Lucas SB, Obura M, Okelo C, Okuku P. Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):542-9. PubMed ID: 8151184 [Abstract] [Full Text] [Related]
6. Protective effect of intradermal BCG against leprosy; a case-control study in central Brazil. Rodrigues ML, Silva SA, Neto JC, de Andrade AL, Martelli CM, Zicker F. Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):335-9. PubMed ID: 1474274 [Abstract] [Full Text] [Related]
7. ILEP organisations should strive for high BCG coverage in communities at risk of leprosy. Velema JP, Ogbeiwi OI. Lepr Rev; 2007 Jun; 78(2):88-101. PubMed ID: 17824479 [Abstract] [Full Text] [Related]
8. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India. Zodpey SP, Ambadekar NN, Thakur A. Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132 [Abstract] [Full Text] [Related]
9. BCG revaccination does not protect against leprosy in the Brazilian Amazon: a cluster randomised trial. Cunha SS, Alexander N, Barreto ML, Pereira ES, Dourado I, Maroja Mde F, Ichihara Y, Brito S, Pereira S, Rodrigues LC. PLoS Negl Trop Dis; 2008 Feb 13; 2(2):e167. PubMed ID: 18270542 [Abstract] [Full Text] [Related]
10. Effectiveness of bacillus Calmette-Guerin (BCG) vaccination in the prevention of leprosy; a case-finding control study in Nagpur, India. Zodpey SP, Shrikhande SN, Salodkar AD, Maldhure BR, Kulkarni SW. Int J Lepr Other Mycobact Dis; 1998 Sep 13; 66(3):309-15. PubMed ID: 9934357 [Abstract] [Full Text] [Related]
13. Protective effect of BCG against leprosy and its subtypes: a case-control study in southern Vietnam. Thuc NV, Abel L, Lap VD, Oberti J, Lagrange PH. Int J Lepr Other Mycobact Dis; 1994 Dec 13; 62(4):532-8. PubMed ID: 7868950 [Abstract] [Full Text] [Related]
14. BCG vaccination in leprosy: final results of the trial in Karimui, Papua New Guinea, 1963-79. Bagshawe A, Scott GC, Russell DA, Wigley SC, Merianos A, Berry G. Bull World Health Organ; 1989 Dec 13; 67(4):389-99. PubMed ID: 2680140 [Abstract] [Full Text] [Related]
17. Tuberculin reactivity and tuberculosis epidemiology in the Pakaanóva (Wari') Indians of Rondônia, south-western Brazilian Amazon. Escobar AL, Coimbra CE, Camacho LA, Santos RV. Int J Tuberc Lung Dis; 2004 Jan 13; 8(1):45-51. PubMed ID: 14974745 [Abstract] [Full Text] [Related]
18. Comparative leprosy vaccine trial in south India. Gupte MD, Vallishayee RS, Anantharaman DS, Nagaraju B, Sreevatsa, Balasubramanyam S, de Britto RL, Elango N, Uthayakumaran N, Mahalingam VN, Lourdusamy G, Ramalingam A, Kannan S, Arokiasamy J. Indian J Lepr; 1998 Jan 13; 70(4):369-88. PubMed ID: 10189587 [Abstract] [Full Text] [Related]
19. Effect of BCG on the risk of leprosy in an endemic area: a case control study. Muliyil J, Nelson KE, Diamond EL. Int J Lepr Other Mycobact Dis; 1991 Jun 13; 59(2):229-36. PubMed ID: 2071979 [Abstract] [Full Text] [Related]
20. Protective efficacy of BCG against leprosy in São Paulo. Lombardi C, Pedrazzani ES, Pedrazzani JC, Filho PF, Zicker F. Bull Pan Am Health Organ; 1996 Mar 13; 30(1):24-30. PubMed ID: 8919722 [Abstract] [Full Text] [Related] Page: [Next] [New Search]